Atlas

FDA-Inspected Site

Bristol-Myers Squibb Company

14 FDA inspections are on record for Bristol-Myers Squibb Company in New Brunswick, United States.

Clean· No action indicated

New Brunswick, United States · Last updated July 9, 2026

Overview

  • 14 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-12-12.

At a glance

Inspections

14

Form 483s

2

EIRs

1

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
8 Dec 2025 – 12 Dec 2025Human DrugsClean
27 Nov 2023 – 1 Dec 2023Human DrugsClean
4 Oct 2017 – 13 Oct 2017Human DrugsClean
30 Sep 2014 – 10 Oct 2014Human DrugsClean
21 Nov 2013 – 22 Nov 2013Human DrugsClean
5 May 2011Not recordedClean
22 Mar 2010Not recordedClean
20 Nov 2008Not recorded483View 483 →
14 Apr 2008Not recorded483On file
21 Dec 2007Not recordedClean
7 May 2004Not recordedClean
12 Mar 2003Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

20 Nov 2008
21 CFR 211.68(a)

Calibration/Inspection/Checking not done

Cited by Annemarie Bodnar

Investigators

FDA investigators tied to this site in the record.

Michael Serrano2 insp.
Denise M Visco2 insp.
Nicholas A Violand2 insp.
Christopher Bastedo1 insp.
Erin M Mcdowell1 insp.
Andrew R Wasko1 insp.
Annemarie Bodnar1 insp.
Byungja E Marciante1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Bristol-Myers Squibb Company's 2 Form 483s

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat